Statistics

Total Visits

Views
BIM and SHP2 expression levels to predict clinical outcome to EGFR tyrosine kinase inhibitors (TKI) in EGFR-mutant non-small-cell lung cancer (NSCLC) patients (p)90

Select a period of time:

Number of views in the range

Views
BIM and SHP2 expression levels to predict clinical outcome to EGFR tyrosine kinase inhibitors (TKI) in EGFR-mutant non-small-cell lung cancer (NSCLC) patients (p)6

Views

Views
December 20253
January 20261
February 20260
March 20262
April 20260
May 20260
June 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States2
Brazil1
Sweden1
Uruguay1
Venezuela1
 

Top cities views

Views
Montevideo1
San Jose1
Stockholm1
Valencia1